サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386580

間質血管細胞群市場レポート：2030年までの動向、予測、競合分析

Stromal Vascular Fraction Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

間質血管細胞群市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

間質血管細胞群の動向と予測

世界の間質血管細胞群市場は、2024年から2030年までのCAGRが5.1%で、2030年までに推定1億2,300万米ドルに達すると予想されています。この市場の主な促進要因は、骨格や筋肉疾患の有病率の増加、幹細胞治療に関する認知度や知識の向上、再生医療への動きの増加、多くの前臨床および臨床研究の試みなどです。世界の間質血管細胞群市場の将来は、病院、専門クリニック、幹細胞バンク/研究所の各市場における機会によって有望視されています。

間質血管細胞群市場の洞察

Lucintelは、予測期間中、軟部組織への応用が最大のセグメントであり続けると予測しています。

アジア太平洋地域は、地方における民間病院の増加など、民間ヘルスケア施設の拡大が続いているため、予測期間中も最大地域であり続けるでしょう。間質血管フラクションは、最先端技術の開発と需要の高まりに拍車をかけ、継続的な研究開発イニシアチブの恩恵を受けるでしょう。

本レポートでは、以下の11の主要な質問に答えている：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どの分野がより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の間質血管細胞群市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の間質血管細胞群市場の動向（2018-2023）と予測（2024-2030）
  • 製品別の世界の間質血管細胞群市場
    • SVFアスピレーション製品
    • SVF転送製品
    • SVF絶縁製品
  • 用途別の世界の間質血管細胞群市場
    • 化粧品用途
    • 整形外科への応用
    • 軟組織への応用
    • その他
  • 最終用途別の世界の間質血管細胞群市場
    • 病院
    • 専門クリニック
    • 幹細胞バンク/研究所
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の間質血管細胞群市場
  • 北米間質血管細胞群市場
  • 欧州の間質血管細胞群市場
  • アジア太平洋間質血管細胞群市場
  • その他地域間質血管細胞群市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品別の世界の間質血管細胞群市場の成長機会
    • 用途別の世界の間質血管細胞群市場の成長機会
    • 最終用途別の世界の間質血管細胞群市場の成長機会
    • 地域別の世界の間質血管細胞群市場の成長機会
  • 世界の間質血管細胞群市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の間質血管細胞群市場の能力拡大
    • 世界の間質血管細胞群市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Cytori Therapeutics
  • IntelliCell BioSciences
  • Cellular Biomedicines Group
  • Lifecell
  • Tissue Genesis
  • InGeneron
  • Human med
  • Hairline International
  • Genesis Biosystems
  • Kyocera
目次

Stromal Vascular Fraction Trends and Forecast

The future of the global stromal vascular fraction market looks promising with opportunities in the hospital, specialty clinic, and stem cell banks/laboratory markets. The global stromal vascular fraction market is expected to reach an estimated $123 million by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of skeletal and muscular ailments, growing recognition and knowledge regarding stem cell therapy, increasing movement towards regenerative medicine, and numerous pre-clinical and clinical research endeavors.

A more than 150-page report is developed to help in your business decisions.

Stromal Vascular Fraction by Segment

The study includes a forecast for the global stromal vascular fraction by product, application, end use, and region.

Stromal Vascular Fraction Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • SVF Aspiration Products
  • SVF Transfer Products
  • SVF Isolation Products

Stromal Vascular Fraction Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cosmetic Applications
  • Orthopedic Applications
  • Soft Tissue Applications
  • Others

Stromal Vascular Fraction Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Stem Cell Banks/Laboratories
  • Others

Stromal Vascular Fraction Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Stromal Vascular Fraction Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stromal vascular fraction companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stromal vascular fraction companies profiled in this report include-

  • Cytori Therapeutics
  • Intellicell Biosciences
  • Cellular Biomedicines Group
  • Lifecell
  • Tissue Genesis
  • Ingeneron
  • Human Med
  • Hairline International
  • Genesis Biosystems
  • Kyocera

Stromal Vascular Fraction Market Insights

Lucintel forecasts that soft tissue application will remain the largest segment over the forecast period.

APAC will remain the largest region over the forecast period due to ongoing expansion of private healthcare facilities, including a rising number of private hospitals in rural regions, stromal vascular fraction stands to benefit from ongoing research and development initiatives, spurred by the growing development and demand for cutting-edge technologies.

Features of the Global Stromal Vascular Fraction Market

Market Size Estimates: Stromal vascular fraction market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Stromal vascular fraction market size by product, application, end use, and region in terms of value ($M).

Regional Analysis: Stromal vascular fraction market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and regions for the stromal vascular fraction market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the stromal vascular fraction market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the stromal vascular fraction market size?

Answer: The global stromal vascular fraction market is expected to reach an estimated $123 million by 2030.

Q.2 What is the growth forecast for stromal vascular fraction market?

Answer: The global stromal vascular fraction market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the stromal vascular fraction market?

Answer: The major drivers for this market are increasing prevalence of skeletal and muscular ailments, growing recognition and knowledge regarding stem cell therapy, increasing movement towards regenerative medicine, and numerous pre-clinical and clinical research endeavors.

Q4. What are the major segments for stromal vascular fraction market?

Answer: The future of the global stromal vascular fraction market looks promising with opportunities in the hospital, specialty clinic, and stem cell banks/laboratory markets.

Q5. Who are the key stromal vascular fraction market companies?

Answer: Some of the key stromal vascular fraction companies are as follows:

  • Cytori Therapeutics
  • Intellicell Biosciences
  • Cellular Biomedicines Group
  • Lifecell
  • Tissue Genesis
  • Ingeneron
  • Human Med
  • Hairline International
  • Genesis Biosystems
  • Kyocera

Q6. Which stromal vascular fraction market segment will be the largest in future?

Answer: Lucintel forecasts that soft tissue application will remain the largest segment over the forecast period.

Q7. In stromal vascular fraction market, which region is expected to be the largest in next 5 years?

Answer: APAC will remain the largest region over the forecast period due to ongoing expansion of private healthcare facilities, including a rising number of private hospitals in rural regions, stromal vascular fraction stands to benefit from ongoing research and development initiatives, spurred by the growing development and demand for cutting-edge technologies.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the stromal vascular fraction market by product (SVF aspiration products, SVF transfer products, and SVF isolation products), application (cosmetic applications, orthopedic applications, soft tissue applications, and others), end use (hospitals, specialty clinics, stem cell banks/laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stromal Vascular Fraction Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Stromal Vascular Fraction Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Stromal Vascular Fraction Market by Product
    • 3.3.1: SVF Aspiration Products
    • 3.3.2: SVF Transfer Products
    • 3.3.3: SVF Isolation Products
  • 3.4: Global Stromal Vascular Fraction Market by Application
    • 3.4.1: Cosmetic Applications
    • 3.4.2: Orthopedic Applications
    • 3.4.3: Soft Tissue Applications
    • 3.4.4: Others
  • 3.5: Global Stromal Vascular Fraction Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Clinics
    • 3.5.3: Stem Cell Banks/Laboratories
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Stromal Vascular Fraction Market by Region
  • 4.2: North American Stromal Vascular Fraction Market
    • 4.2.1: North American Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.2.2: North American Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
  • 4.3: European Stromal Vascular Fraction Market
    • 4.3.1: European Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.3.2: European Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
  • 4.4: APAC Stromal Vascular Fraction Market
    • 4.4.1: APAC Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.4.2: APAC Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
  • 4.5: ROW Stromal Vascular Fraction Market
    • 4.5.1: ROW Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.5.2: ROW Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Stromal Vascular Fraction Market by Product
    • 6.1.2: Growth Opportunities for the Global Stromal Vascular Fraction Market by Application
    • 6.1.3: Growth Opportunities for the Global Stromal Vascular Fraction Market by End Use
    • 6.1.4: Growth Opportunities for the Global Stromal Vascular Fraction Market by Region
  • 6.2: Emerging Trends in the Global Stromal Vascular Fraction Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Stromal Vascular Fraction Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stromal Vascular Fraction Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Cytori Therapeutics
  • 7.2: IntelliCell BioSciences
  • 7.3: Cellular Biomedicines Group
  • 7.4: Lifecell
  • 7.5: Tissue Genesis
  • 7.6: InGeneron
  • 7.7: Human med
  • 7.8: Hairline International
  • 7.9: Genesis Biosystems
  • 7.10: Kyocera